Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis C
{{output}}
Chronic infection with hepatitis C virus (HCV) affects an estimated 0.1%-2% of the pediatric population in the United States. While the clinical course in young children is indolent, adolescents who contract HCV have a disease course similar to adults, with a ... ...
